Working locally to create solutions for India and the world
PATH has worked in India since 1978, improving health and saving lives through creativity and collaboration with local partners. India is a country of both tremendous health needs and growing health resources. As it prospers, the opportunity to develop health solutions in India, for India has never been greater. Many of these solutions have applications for low-resource countries far beyond its borders.
PATH plays an important intermediary role, working alongside local companies and public-sector partners to develop new tools and roll them out in communities across the country and beyond. We bring technical know-how to the tasks of developing new vaccines, improving the health of mothers and newborns through nutrition and safer births, controlling tuberculosis (TB) in the crowded slums of Mumbai, and much more.
Our work in India
Vaccines: For nearly 10 years PATH supported the introduction and scale-up of a vaccine against Japanese encephalitis, one of the leading viral causes of acute encephalitis, in India and neighboring countries. Currently, we are supporting encephalitis treatment centers to build the skills of health personnel, create community awareness, and strengthen data management to identify and treat encephalitis from other causes.
PATH also partnered with Serum Institute of India Private Ltd. to develop an affordable vaccine for epidemic meningitis A in sub-Saharan Africa. Known as MenAfriVac®, the vaccine was developed in less than ten years and at one-tenth the cost of a typical vaccine. Since the introduction of MenAfriVac in December 2010, recurring epidemics have been eliminated.
Innovative technology: Our work on MenAfriVac is a prime example of how PATH engages Indian companies and experts to improve health. We are engaged in similar collaborations to address TB, diagnostics, and nutrition—coordinating technical support, grant funding, and capital investment through our Global Health Innovation Hub.
Tuberculosis: India has more TB cases than any other country in the world, many of them in heavily populated urban slums. In Mumbai, PATH supports a unique public-private partnership that is increasing the private sector’s contribution to universal access to high-quality TB services—a model that could be adapted to other diseases. PATH has also provided technical assistance to strengthen TB laboratory networks.
Nutrition: To ensure that all babies have access to the critical nutrients in breast milk, PATH helped the government develop national guidelines for breast-milk banking and set up milk banking systems using cost-saving technologies, such as a pasteurization monitoring process guided by mobile phones. We have also worked closely with Indian partners on rice fortification, establishing a low-cost, high-quality production facility that now reaches hundreds of thousands of children every day, and developing a market and distribution system through India’s public- and private-sector channels.
MenAfriVac is a registered trademark of Serum Institute of India Private Ltd.
Photo: PATH/Gabe Bienczycki.
Bringing together children, vaccines, and health worker Asha Thakur
TB can usually be cured, but time is of the essence
Everyday tools to make childbirth safer
An overview of our work in India